SEC Form 4 · accession 0001127602-17-031880
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vecheslav A Elagin
Officer — EVP, R&D & Chf Scientific Off
Period of report
Nov 8, 2017
Accepted (ET)
Nov 13, 2017 · 3:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 8, 2017 | A | 7,500 | $0.00 | A | 55,989 | D | |
| Common StockF2 | Nov 9, 2017 | D | 10,000 | $0.00 | D | 45,989 | D | |
| Common Stock | holding | — | — | — | 80 | I | Held in Meridian Savings & Investment Plan (401K) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F3 | $14.65 | Nov 8, 2017 | A | 12,500 | A | — | Nov 8, 2027 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest in full (100%) on November 15, 2021.
- F2These restricted stock units were awarded under the 2012 Stock Incentive Plan and were subject to attainment by the Company of a specified earnings target for fiscal 2017. As the Company did not reach the target, these restricted stock units have been cancelled.
- F3These options are granted awarded under the 2012 Stock Incentive Plan and vest in full (100%) on November 15, 2021.